Skip to main content
Dong Xie, MD, Pathology, Tampa, FL

DongLinXieMD

Pathology Tampa, FL

Blood Banking & Transfusion Medicine, Dermatopathology, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Xie?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 21 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    5751 Hoover Blvd
    Tampa, FL 33634
    Phone+1 813-886-8334
    Fax+1 813-890-0143

Summary

  • Dr. Dong Xie, MD is a board certified pathologist in Tampa, Florida. She is currently licensed to practice medicine in Florida, Tennessee, and West Virginia. She is affiliated with Tampa General Hospital and AdventHealth Tampa.

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Dermatopathology, 1998 - 1999
  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Blood Banking/Transfusion Medicine, 1997 - 1998
  • Ohio State University Hospital
    Ohio State University HospitalResidency, Pathology-Anatomic and Clinical, 1993 - 1997
  • Shanghai Medical University
    Shanghai Medical UniversityClass of 1984

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2000 - 2025
  • WV State Medical License
    WV State Medical License 1997 - 2025
  • TN State Medical License
    TN State Medical License 2004 - 2018
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Dermatopathology

Publications & Presentations

PubMed

Press Mentions

  • Frontier Biotechnologies' Long-Acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS Patients
    Frontier Biotechnologies' Long-Acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS PatientsOctober 27th, 2021
  • Frontier Biotechnologies' First Long-Acting Injectable (Aikening(R)), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for Patients
    Frontier Biotechnologies' First Long-Acting Injectable (Aikening(R)), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for PatientsJuly 19th, 2021